Author:
Ernst D.,Schmidt R.E.,Witte T.
Publisher
Springer Science and Business Media LLC
Reference42 articles.
1. Smitten AL, Choi HK, Hochberg MC et al (2008) The risk of hospitalized infection in patients with rheumatoid arthritis. J Rheumatol 35(3):387–393
2. Kuschal C, Thoms K-M, Schubert S et al (2012) Skin cancer in organ transplant recipients: effects of immunosuppressive medications on DNA repair. Exp Dermatol 21(1):2–6
3. Bernatsky S, Clarke AE, Ramsey-Goldman R (2008) Cancer in systemic lupus: what drives the risk? Cancer Causes Control 19(10):1413–1414
4. Dartel SAA van, Fransen J, Kievit W et al (2013) Predictors for the 5-year risk of serious infections in patients with rheumatoid arthritis treated with anti-tumor necrosis factor therapy: a cohort study in the Dutch Rheumatoid Arthritis Monitoring (DREAM) registry. Rheumatology
5. Strangfeld A, Eveslage M, Schneider M et al (2011) Treatment benefit or survival of the fittest: what drives the time-dependent decrease in serious infection rates under TNF inhibition and what does this imply for the individual patient? Ann Rheum Dis 70(11):1914–1920